(Click to show)

CDKN2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), HGNC:1787, ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, TP16, p14, p14ARF, p16, p16INK4, p16INK4a, p19, CDK4 inhibitor p16-INK4, cell cycle negative regulator beta, cyclin-, Protein CDKN2A, CDKN2A protein, Protein cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) protein, Protein HGNC:1787, HGNC:1787 protein, Protein ARF, ARF protein, Protein CDK4I, CDK4I protein, Protein CDKN2, CDKN2 protein, Protein CMM2, CMM2 protein, Protein INK4, INK4 protein, Protein INK4a, INK4a protein, Protein MLM, MLM protein, Protein MTS1, MTS1 protein, Protein TP16, TP16 protein, Protein p14, p14 protein, Protein p14ARF, p14ARF protein, Protein p16, p16 protein, Protein p16INK4, p16INK4 protein, Protein p16INK4a, p16INK4a protein, Protein p19, p19 protein, Protein CDK4 inhibitor p16-INK4, CDK4 inhibitor p16-INK4 protein, Protein cell cycle negative regulator beta, cell cycle negative regulator beta protein, Protein cyclin-, cyclin- protein